(Q43913282)

28 November 2017

title

Troglitazone activates p21Cip/WAF1 through the ERK pathway in HCT15 human colorectal cancer cells (English)

1 reference

28 November 2017

1 reference

7

Kang-Yell Choi

1 reference

28 November 2017

Jin-Ah Kim

1

1 reference

28 November 2017

Ki-Sook Park

2

1 reference

28 November 2017

Ha-Il Kim

3

1 reference

28 November 2017

So-Young Oh

4

1 reference

28 November 2017

Yongho Ahn

5

1 reference

28 November 2017

Jong-Won Oh

6

1 reference

28 November 2017

language of work or name

English

0 references

publication date

1 May 2002

1 reference

28 November 2017

1 reference

28 November 2017

volume

179

1 reference

28 November 2017

issue

2

1 reference

28 November 2017

page(s)

185-195

1 reference

Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900869-2

7 January 2021

An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900869-2

7 January 2021

The structure-activity relationship between peroxisome proliferator-activated receptor gamma agonism and the antihyperglycemic activity of thiazolidinediones

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900869-2

7 January 2021

Adipogenesis and obesity: rounding out the big picture

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900869-2

7 January 2021

Effects of ligand activation of peroxisome proliferator-activated receptor gamma in human prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900869-2

7 January 2021

Troglitazone inhibits vascular smooth muscle cell growth and intimal hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900869-2

7 January 2021

Troglitazone suppresses cell growth of myeloid leukemia cell lines by induction of p21WAF1/CIP1 cyclin-dependent kinase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900869-2

7 January 2021

The effects of thiazolidinediones on vascular smooth muscle cell activation by angiotensin II

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900869-2

7 January 2021

Differentiation and reversal of malignant changes in colon cancer through PPARgamma

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900869-2

7 January 2021

p21(WAF1) is required for butyrate-mediated growth inhibition of human colon cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900869-2

7 January 2021

Butyrate activates the WAF1/Cip1 gene promoter through Sp1 sites in a p53-negative human colon cancer cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900869-2

7 January 2021

WAF1, a potential mediator of p53 tumor suppression

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900869-2

7 January 2021

Raf-induced proliferation or cell cycle arrest is determined by the level of Raf activity with arrest mediated by p21Cip1.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900869-2

7 January 2021

High-intensity Raf signal causes cell cycle arrest mediated by p21Cip1.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900869-2

7 January 2021

Differential regulation of MAP kinase cascade in human colorectal tumorigenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900869-2

7 January 2021

Mutator phenotypes in human colorectal carcinoma cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900869-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900869-2

7 January 2021

Lessons from hereditary colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900869-2

7 January 2021

The MEK pathway is required for stimulation of p21(WAF1/CIP1) by transforming growth factor-beta

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900869-2

7 January 2021

Cell cycle targets of Ras/Raf signalling

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900869-2

7 January 2021

PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900869-2

7 January 2021

MEK inhibitors: the chemistry and biological activity of U0126, its analogs, and cyclization products

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900869-2

7 January 2021

10.1016/S0304-3835(01)00869-2

Identifiers

DOI

1 reference

release_asm23dtyrvaz3elkzf3nsebawq

28 November 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/asm23dtyrvaz3elkzf3nsebawq

24 November 2022

mapped directly with Wikidata item

1 reference